Also categorized in BoardMoves:
What Lies Ahead For Chesapeake As McClendon Exits?
x hide permanently

Varian Medical Systems Appoints Anat Ashkenazi to Board

StreetInsider.com

Varian (NYSE: VAR) today announced that Anat Ashkenazi, senior vice president, controller and chief financial officer (CFO) at Lilly Research Labs, has been appointed to the Varian Board of Directors, effective December 1, 2018. She will serve on the Audit Committee and the Ethics & Compliance Committee...

Mentions: Ethics Audit Committee Compliance